$0.58 $0.02 (0.0%)

04:30 PM EDT on 05/20/19

Applied DNA Sciences Inc. (NASDAQ:APDN)

CAPS Rating: 1 out of 5

Current Price $0.58 Mkt Cap $21.7M
Open $0.58 P/E Ratio 0.00
Prev. Close $0.58 Div. (Yield) $0.00 (0.0%)
Daily Range $0.55 - $0.58 Volume 24,580
52-Wk Range $0.35 - $0.92 Avg. Daily Vol.


This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

10 Outperform
23 Underperform

All-Star Players

1 Outperform
20 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:APDN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

yip (< 20)
Submitted March 02, 2015

Though unprofitable to date this High Tech "Bio" Growth stock has enormous potential. Proven and unparalleled in the Muti-Billion dollar anti-counterfeit/theft space. Its recent uplisting to NASDAQ should help make it a household name in the not too… More

jed71 (99.74)
Submitted January 09, 2017

Well, this certainly doesn’t give me much comfort: “We are a Delaware corporation, which was initially formed in 1983 under the laws of the State of Florida as Datalink Systems, Inc. In 1998, we reincorporated in Nevada, and in 2002, we changed our… More



Fools bearish on NASDAQ:APDN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about APDN.


Member Avatar SmartAce (99.96) Submitted: 2/28/2019 3:33:48 PM : Underperform Start Price: $0.67 NASDAQ:APDN Score: +15.33

[spelling bee]
Your word is 'embarrassing'
"Oh I don't mind, you can say it"
No, it's really 'embarrassing'
"Ok, I promise not to laugh"


Member Avatar jed71 (99.74) Submitted: 1/9/2017 11:56:04 AM : Underperform Start Price: $1.81 NASDAQ:APDN Score: +93.30

Well, this certainly doesn’t give me much comfort:

“We are a Delaware corporation, which was initially formed in 1983 under the laws of the State of Florida as Datalink Systems, Inc. In 1998, we reincorporated in Nevada, and in 2002, we changed our name to our current name, Applied DNA Sciences, Inc. In December 2008, we reincorporated from Nevada to the State of Delaware.
In November 2005, our corporate headquarters were relocated from Los Angeles, California to the Long Island High Technology Incubator at Stony Brook University in Stony Brook, New York, where we established laboratories for the manufacture of DNA markers and product prototypes, and DNA authentication. The address of our corporate headquarters is 50 Health Sciences Drive, Stony Brook, New York 11790, and our telephone number is (631) 240-8800. We maintain a website at www.adnas.com where general information about us is available.”

Nor am I incredibly thrilled with old habits such as this:

“All warrant, option, share and per share information in this report gives retroactive effect to a one-for-60 reverse stock split that was effective on October 29, 2014.”

It looks like that share balance has been worked back up to a pretty sizeable 26.4MM shares. Maybe that doesn’t seem like a giant amount but consider they had 10.7MM shares back in 2012. I also cannot find where they were ever profitable on an annual basis in the past 5 years. This company seems like its stuck in a rut. Maybe there is a way for them to find a way out, but I am not seeing it. Basically, flat sales on what to me looks like a very old technology. If you cannot make money in this many years on a technology that looks to be from the early 2000’s at this juncture, I don’t see where you’ll ever be able to pull it off. Patents look like they’ll begin expiring in a short few years:

“We believe that our 41 patents, 83 patent applications, 37 registered trademarks, and 8 trademark applications, and our trade secrets, copyrights and other intellectual property rights are important assets for us. Our patents will expire at various times between 2021 and 2032.”

Very small revenue, big GAAP losses, and high expenses do not a good combination make. They burn between $10-12MM a year in cash. With a limited amount of cash remaining ($4.6MM), I expect shareholders will be diluted again here shortly. I see absolutely nothing of value in this offering, but maybe I am missing something.


Member Avatar mcsharkey55 (< 20) Submitted: 3/3/2015 10:19:06 PM : Outperform Start Price: $3.68 NASDAQ:APDN Score: -119.31

Laughable actually. Been long, 8 years now. Accumulated way too much of this crap, and am now concerned with this self-managed mixed shelf. Joining on here for others insights.
Awaiting the DLA to make the move to expand to at least five Federal Stock Groups by June. We've jumped through all the development hoops. IMHO. And this has humbled me.


Find the members with the highest scoring picks in APDN.

Score Leader


whatsthepoint (99.98) Score: +221.81

The Score Leader is the player with the highest score across all their picks in APDN.

Member Name Member
Call Time
Score Commentary
whatisthepoint 97.51 10/12/2015 Underperform 5Y $8.01 -92.76% +40.98% +133.74 0 Comment
JoeySolitro3 98.85 2/18/2016 Underperform 5Y $2.77 -79.06% +48.12% +127.18 0 Comment
MMCapitalMgmt 99.93 11/13/2014 Underperform 5Y $4.05 -85.68% +39.53% +125.21 1 Comment
telecomgirl 54.08 11/12/2015 Underperform 3W $4.10 -85.85% +37.64% +123.49 0 Comment
Zencyclone 30.84 11/4/2015 Underperform 5Y $4.55 -87.25% +34.47% +121.72 0 Comment
TheDumbMoney2 98.28 1/14/2015 Underperform NS $2.78 -79.14% +42.35% +121.49 0 Comment
patatepoil6 99.88 3/14/2016 Underperform 5Y $3.03 -80.86% +40.58% +121.44 0 Comment
giffenbone 99.94 12/15/2014 Underperform 5Y $2.60 -77.69% +40.71% +118.40 0 Comment
NobleOrSomeBull 99.56 5/11/2015 Underperform 5Y $2.50 -76.80% +34.33% +111.13 0 Comment
foolishfun4me 99.47 12/9/2016 Underperform 5Y $2.15 -73.02% +25.59% +98.61 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for APDN.